These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22581121)

  • 1. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.
    Jankowski W; Saleh T; Pai MT; Sriram G; Birge RB; Kalodimos CG
    Nat Chem Biol; 2012 May; 8(6):590-6. PubMed ID: 22581121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural biology: CrkL is not Crk-like.
    Kobashigawa Y; Inagaki F
    Nat Chem Biol; 2012 May; 8(6):504-5. PubMed ID: 22596199
    [No Abstract]   [Full Text] [Related]  

  • 3. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design.
    Panigrahi S; Stetefeld J; Jangamreddy JR; Mandal S; Mandal SK; Los M
    PLoS One; 2012; 7(1):e28395. PubMed ID: 22253690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction.
    Koval AP; Karas M; Zick Y; LeRoith D
    J Biol Chem; 1998 Jun; 273(24):14780-7. PubMed ID: 9614078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M; Salgia R
    Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
    Antoku S; Mayer BJ
    J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R; van Wijk A; Haataja L; Heisterkamp N; Groffen J
    J Biol Chem; 1997 Dec; 272(51):32649-55. PubMed ID: 9405482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene.
    Senechal K; Halpern J; Sawyers CL
    J Biol Chem; 1996 Sep; 271(38):23255-61. PubMed ID: 8798523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop.
    Seo JH; Suenaga A; Hatakeyama M; Taiji M; Imamoto A
    Mol Cell Biol; 2009 Jun; 29(11):3076-87. PubMed ID: 19307307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.
    Heikkinen LS; Kazlauskas A; Melén K; Wagner R; Ziegler T; Julkunen I; Saksela K
    J Biol Chem; 2008 Feb; 283(9):5719-27. PubMed ID: 18165234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation.
    Heaney C; Kolibaba K; Bhat A; Oda T; Ohno S; Fanning S; Druker BJ
    Blood; 1997 Jan; 89(1):297-306. PubMed ID: 8978305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2.
    Schmoker AM; Weinert JL; Kellett KJ; Johnson HE; Joy RM; Weir ME; Ebert AM; Ballif BA
    Biochem J; 2017 Nov; 474(23):3963-3984. PubMed ID: 29025973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo regulation of CrkII and CrkL proto-oncogenes in the uterus by insulin-like growth factor-I. Differential effects on tyrosine phosphorylation and association with paxillin.
    Butler AA; Blakesley VA; Koval A; deJong R; Groffen J; LeRoith D
    J Biol Chem; 1997 Oct; 272(44):27660-4. PubMed ID: 9346905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
    Sanders MA; Ampasala D; Basson MD
    J Biol Chem; 2009 Jan; 284(1):27-35. PubMed ID: 19004829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRKL binding to BCR-ABL and BCR-ABL transformation.
    Kolibaba KS; Bhat A; Heaney C; Oda T; Druker BJ
    Leuk Lymphoma; 1999 Mar; 33(1-2):119-26. PubMed ID: 10194128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.